Jonathan Smith, Author at Labiotech.eu

About

Reporter for Labiotech. I hail from the UK. I was born in Bristol, studied Neuroscience in the University of Bristol, and trained mice in Eisai, Hertfordshire, for one year. I then tickled locusts for my Ph.D. at the University of Leicester, before eventually ending up here!
Out of the office, I travel, play video games and board games, drink beer and play the piano.

Articles by Jonathan Smith

Leuven biotech of the week wikimedia Edited

Startup Scout 5 Oct 2018

This Biotech Sticks Bacterial Proteins Together to Fight Antibiotic Resistance

This week’s biotech has its base in Leuven, Belgium. The newly-founded Aelin Therapeutics hopes to combat antibiotic resistance by doing the pharmacological equivalent of boiling an egg. Mission: To develop…

October 5, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 4 Oct 2018

This Year’s Nobel Prizes Highlight Advances in Biotechnology

Immune system brakes, optical tweezers, and enzyme evolution. Three separate subjects that span this year’s Nobel Prizes in Physiology or Medicine, Physics and Chemistry. Despite the differences in theory, however,…

October 4, 2018 - 5 minutesmins - By Jonathan Smith

Inotrem Septic Shock Blood Infection Header

News and Trends 2 Oct 2018

Septic Shock Drug Shows Promise for Personalized Medicine

Septic shock may no longer be as shocking in the future, as a Phase IIa trial brings hope for a personalized immunomodulatory treatment from the French biotech Inotrem. In…

October 2, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 1 Oct 2018

Cancer-Sniffing Diagnostics Company Secures €43.1M Funding

Intoxication is not the only condition that we could diagnose with breathalyzers. The UK-US company Owlstone Medical has secured €43.1M funding to help commercialize its tech that ‘smells’ cancer in…

October 1, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 28 Sep 2018

Roche Acquires UK Cancer Immunotherapy Biotech in Deal Worth up to €655M

Tusk Therapeutics has been acquired by Swiss pharma giant Roche, which aims to develop one of its lead immunological cancer treatments. Roche has given Tusk’s shareholders €70M upfront, with up…

September 28, 2018 - 2 minutesmins - By Jonathan Smith

Startup Scout 28 Sep 2018

This Spanish Biotech Helps Personalize Post-Kidney Transplant Care

We arrive in the city of Madrid this week to showcase Biohope, which is developing a technique to combat kidney transplant rejection by tailoring immunosuppressant treatments to individual patients. …

September 28, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 26 Sep 2018

Spanish Biotech Raises €21.3M To Advance Rare Disease Pipeline

Rare genetic diseases in the central nervous system may be less of a headache in future, as Barcelona-based biotech Minoryx has raised €21.3M in series B fundraising to test its…

September 26, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 26 Sep 2018

Fish Oils Finally Reel in Positive Results for Cardiovascular Disease

Purified fish oil can reduce patients’ risks for adverse cardiovascular events by 25%, according to US-Irish Biotech Amarin’s Phase III trial results. The treatment, called Vascepa, significantly reduced the risk…

September 26, 2018 - 2 minutesmins - By Jonathan Smith

aktiia blood pressure people crossing v2

More News! 25 Sep 2018

24-Hour Blood Pressure Bracelet Could Combat Hypertension

For those with blood pressure problems who hate blood pressure cuffs, hope is here. Swiss biotech aktiia has raised €3.6M to market a medical bracelet that could monitor your blood…

September 25, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 24 Sep 2018

Gene Therapy Improves Eyesight of Patients With Inherited Blindness

UK startup Nightstar Therapeutics has reported good safety and early signs of visual improvements in a Phase I/II trial with a gene therapy for a rare form of inherited blindness.…

September 24, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 20 Sep 2018

RNA Therapy Shows Promise for Treating Liver Cancer

British biotech MiNA Therapeutics’ innovative RNA treatment may enhance liver cancer patients’ response to standard cancer therapies, suggest early results from a Phase I/IIa clinical trial. When they received the…

September 20, 2018 - 2 minutesmins - By Jonathan Smith

More News! 19 Sep 2018

Argenx Attracts Huge €250M Investment Following Positive Phase II Trial

Belgian biotech Argenx raised over €250M in public investment on the Nasdaq Stock Market after announcing positive Phase II results for its lead autoimmune drug candidate. The company now plans…

September 19, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 18 Sep 2018

Cockle Molecules Could Help Fight Cancer

As you eat your plate of delicious cockles, spare a thought for how their sugars might help to tackle cancer, suggest researchers from the University of Salford, UK. Testing cockle-derived…

September 18, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 17 Sep 2018

Brewing Pheromones for Pest Control

Harmful pesticides on your food may be less of a worry in the future, as a Danish biotech company has received a €3M investment to market a safer and more…

September 17, 2018 - 2 minutesmins - By Jonathan Smith

In Depth 12 Jul 2018

How Plant Biotechnology Can Give Us Better Food and Medicines

From super crops to better medicines, biotechnology from plants could make a big difference in our lives. Here’s how. What have plants ever done for us? Well, a colossal amount…

July 12, 2018 - 4 minutesmins - By Jonathan Smith

Beyond Biotech - the podcast from Labiotech

View More

Newsletter Signup - Sidebar

"*" indicates required fields

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering